Alvotech and Dr. Reddy’s collaborate for commercialization of AVT03 (denosumab)
Dr. Reddy’s gets exclusive commercialization rights in the United States (U.S.) as well as semi-exclusive rights in Europe and United Kingdom (UK)
Dr. Reddy’s gets exclusive commercialization rights in the United States (U.S.) as well as semi-exclusive rights in Europe and United Kingdom (UK)
For use with Hamamatsu Images acquired with the NanoZoomer S360MD slide scanner
Sanofi will leverage this partnership to provide access to proprietary data to develop AI models
Operationally ready by 2029, it will be the Company’s first-ever facility to cover the full manufacturing process for ADCs
The collaboration aims to bolster healthcare entrepreneurship
The award recognizes powerful science–industry collaborations for social good
According to IQVIATM sales data for the 12-month period ending March 2024, the Combigan Ophthalmic Solution, 0.2%|0.5% market achieved annual sales of approximately $290.0 million
Annapurna will lead the company in India ensuring patient access to its highly innovative medicines and vaccines
EBITDA for the quarter stood at Rs 964 crore, representing an EBITDA margin of 24%
Subscribe To Our Newsletter & Stay Updated